Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 70518-4246

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 70518-4246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Cyclobenzaprine Hydrochloride 15 mg extended-release capsules in a bottle label format. The label shows a quantity of 30 capsules and includes the REMEDYREPACK INC. logo. It also features an NDC code 70518-4246-00, manufacturer details, storage instructions, and a barcode.*

FDA Label Image

Structural Formula (Cyclobenzaprine Hydrochloride Extended Release Cap 1)

Chemical structure diagram of Cyclobenzaprine Hydrochloride showing the three connected benzene rings and the molecular formula including a hydrochloride component.*

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 2)

Illustration of a spoon holding a small pile of cream or paste, suggesting a formulation or dosage form related to the product.*

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 3)

An instructional illustration showing a hand holding and opening a capsule labeled '10P'. The image demonstrates the process of splitting or opening the capsule for use.*

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 4)

An instructional illustration demonstrating how to twist and break a capsule, with arrows indicating the direction to turn the capsule halves apart by hand, showing the capsule labeled "TCI." This image guides users on capsule opening technique.*

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 5)

An instructional illustration showing a hand sprinkling small beads or granules from a capsule onto a spoon, suggesting capsule contents can be administered this way.*

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 6)

An instructional illustration showing a woman taking a capsule orally, demonstrating the proper method of swallowing the medication.*

FDA Label Image

1 (Cyclobenzaprine Hydrochloride Extended Release Cap 7)

An instructional illustration showing a woman drinking from a glass, likely demonstrating oral administration of medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.